These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17482939)

  • 1. Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer.
    Snow SL; Panton RL; Butler LJ; Wilke DR; Rutledge RD; Bell DG; Rendon RA
    Urology; 2007 May; 69(5):941-5. PubMed ID: 17482939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy.
    Davison BJ; Keyes M; Elliott S; Berkowitz J; Goldenberg SL
    BJU Int; 2004 May; 93(7):965-9. PubMed ID: 15142144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
    Gwede CK; Pow-Sang J; Seigne J; Heysek R; Helal M; Shade K; Cantor A; Jacobsen PB
    Cancer; 2005 Oct; 104(7):1381-90. PubMed ID: 16080181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L; Feldman-Stewart D; Brundage MD
    Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The information needed by Canadian early-stage prostate cancer patients for decision-making: stable over a decade.
    Feldman-Stewart D; Brennenstuhl S; Brundage MD
    Patient Educ Couns; 2008 Dec; 73(3):437-42. PubMed ID: 18762405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
    Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information and decision-making preferences of men with prostate cancer.
    Davison BJ; Degner LF; Morgan TR
    Oncol Nurs Forum; 1995 Oct; 22(9):1401-8. PubMed ID: 8539181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ; Goldenberg SL; Gleave ME; Degner LF
    Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
    Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
    J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A purpose-based evaluation of information for patients: an approach to measuring effectiveness.
    Feldman-Stewart D; Brennenstuhl S; Brundage MD
    Patient Educ Couns; 2007 Mar; 65(3):311-9. PubMed ID: 17014979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Information needs of men with prostate cancer and their partners].
    Krol Y; van Dam FS; Horenblas S; Meinhardt W; Muller MJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):431-7. PubMed ID: 10719548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prostate cancer: hedonic prices model of provider-patient interactions and decisions.
    Jani AB; Hellman S
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1158-68. PubMed ID: 17881151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer treatment decisions: a focus group exploration.
    O'Rourke ME; Germino BB
    Oncol Nurs Forum; 1998; 25(1):97-104. PubMed ID: 9460777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.